LuViva Sales, Marketing and Training Center in Budapest
December, 01, 2020.
Established with Medica Bella Women’s Health Clinic to Facilitate Sales and Marketing Starting in 2021
Guided Therapeutics, Inc. (USA), the maker of a rapid and painless testing platform based on its patented biophotonic technology and Newmars Technologies Ltd (Hungary), its LuViva European manufacturing and distribution partner, announced the opening of new LuViva Reference and Training Center (“Center of Excellence”) in Budapest Hungary to support sales and training in Europe. The center is established at Budapest Medica Bella Women’s Health Clinic. The Center’s primary focus will be to introduce and train physicians from all over Europe in the clinical implementation of LuViva. LuViva has received the CE Mark by Newmars Technologies. The CE Mark enables expanded commercialization of LuViva in 27 EU-associated countries totaling a population of 229 million women.
Related to the progress in Europe, the Russian certification process of LuViva is proceeding on a track for approval towards the end of next year. In support of these efforts, new clinical data showing that LuViva detects cervical cancer earlier than the Pap and HPV tests is expected to be published in the beginning of next year in a regional medical journal.